Inoculation with a mixture of VEGFR2-Fc– and FGFR2-Fc–expressing tumor cells showed further significant delay of in vivo tumor growth compared with inoculation with a mixture of Mock and VEGFR2-Fc–expressing tumor cells (Fig. 4c,d). Here, FGFR2 is linked to neoplasm.